BioAtla, Inc.BCABNASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank83
5Y CAGR-14.9%
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

5Y CAGR
-14.9%/yr
Long-term compound
Percentile
P83
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
4 yr
Consecutive growthAccelerating
PeriodValue
202430.91%
2023-14.80%
2022-43.63%
2021-70.99%
2020-231.04%
201969.28%
20180.00%